Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab

Neurocognitive decline is a frequent adverse effect of glioblastoma. Antitumor therapies that are efficacious, as measured by traditional endpoints such as objective response (OR) and progression-free survival (PFS), and have beneficial effects on neurocognitive function (NCF) are of clinical benefi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Wefel, Jeffrey S., Cloughesy, Timothy, Zazzali, James L., Zheng, Maoxia, Prados, Michael, Wen, Patrick Y., Mikkelsen, Tom, Schiff, David, Abrey, Lauren E., Yung, W.K. Alfred, Paleologos, Nina, Nicholas, Martin K., Jensen, Randy, Vredenburgh, James, Das, Asha, Friedman, Henry S.
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2011
Fag:
Clinical Investigations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3107095/
https://ncbi.nlm.nih.gov/pubmed/21558074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nor024
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker